Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 ASX News Incannex Healthcare (ASX:IHL) Send Share Share
Incannex – APIRx Pharmaceuticals Acquisition May 2022 May 12, 2022 | ASX News, Incannex Healthcare (ASX:IHL)
Nyrada Inc (ASX: NYR) Presentation to ASX Small and Mid-Cap Conference Sep 13, 2021 | ASX News, Nyrada Inc (ASX:NYR)